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Resumo
Introdução: Nos últimos anos, a ventilação não invasiva 
(VNI) tornou-se numa opção terapêutica válida nas exa-
cerbações agudas de doentes com doença pulmonar cró-
nica obstrutiva. No entanto, apesar de muito utilizada, 
existe muito pouca informação sobre o desmame deste 
modo ventilatório. Objectivos: Descrever um protocolo 
de desmame baseado em períodos progressivos de des-
continuação de VNI. Métodos: Durante um ano foram 
admitidos 78 doentes na nossa unidade para início de 
VNI devido a exacerbações agudas de doentes com doen-
ça pulmonar crónica obstrutiva. O desmame de VNI era 
considerado em doentes que se apresentavam sem acido-
se e com frequência respiratória inferior a 25 ciclos por 
Abstract
Background: In recent years non-invasive ventila-
tion (NIV) as become a valuable therapeutic op-
tion in exacerbations of patients with chronic pul-
monary obstructive disease. Although widely used 
there is a paucity of information on weaning from 
NIV. Objectives: We aimed to describe the perfor-
mance of a weaning protocol based on progressive 
periods of NIV withdraw. Methods: During a one 
year period we performed NIV in 78 patients with 
acute exacerbation of chronic respiratory failure. 
Weaning was considered in patients with 24 hours 
without acidosis and respiratory rate less than 25 
cycles per minute. Weaning was performed as 
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minuto. O desmane era realizado da seguinte forma: Du-
rante as primeiras 24 horas, em cada 3 horas de período 
diurno o doente estava sem VNI durante uma hora (ex-
cepto à noite); no segundo dia, em cada 3 horas o doente 
estava sem VNI durante 2 horas (excepto à noite), e no 
terceiro dia a VNI era utilizada apenas em período noc-
turno. Resultados: Sessenta doentes iniciaram o proto-
colo de desmame. O tempo médio de VNI foi de 120.9 
horas (17 a 192 horas). Não houve registo de complica-
ções nos doentes que iniciaram este protocolo. Todos 
completaram o protocolo sem necessidade de reinstituir 
VNI ou ventilação invasiva durante o internamento. 
Conclusões: Descrevemos uma taxa excelente de sucesso 
de desmame de VNI em doentes com exacerbações agu-
das de doentes com insuficiência respiratória crónica. 
Apesar de este protocolo implicar uma duração de 72 
horas, os resultados sugerem que estratégias baseadas em 
períodos com e sem VNI são eficazes. No entanto, estra-
tégias menos demoradas merecem investigação.
Rev Port Pneumol 2008; XIV (1): 49-53
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following: during the first 24 hours in each 3 
hours, one hour without NIV (except during night 
period), in the second day in each 3 hours, two 
hours without NIV (except during night period) 
and in the third day NIV was used during the ni-
ght period. Results: Sixty five patients began the 
weaning protocol. Mean NIV time was 120,9 
hours (17 to 192 hours). No adverse effects were 
recorded in patients who began the weaning pro-
tocol. All patients completed the weaning protocol 
with no re-institution of NIV or invasive ventila-
tion during hospitalization. Conclusions: We re-
port an excellent weaning success rate of NIV in 
patients with acute severe exacerbation of CRF. Al-
though our weaning protocol required 72 hours, 
our results suggest that strategies based on periods 
with and with-out NIV are effective. Weather si-
milar less time consuming weaning strategies are 
effective, merits investigation. 
Rev Port Pneumol 2008; XIV (1): 49-53
Key-words: Non-invasive ventilation, chronic respi-
ratory failure, weaning
Introduction
Non-invasive ventilation (NIV) has became 
a valuable therapeutic option in patients 
with severe acute respiratory distress not re-
quiring immediate invasive ventilation. 
NIV is now widely used in many institu-
tions in patients with acute pulmonary oe-
dema and severe exacerbations of patients 
with chronic pulmonary obstructive disease 
(COPD)1. This ventilatory technique is as-
sociated with clinical improvement, less 
need of oro-traqueal intubations and less in-
tensive care stay2-4. Although the potential 
clinical application of NIV is still expan-
ding, there is a consensus about using NIV 
in several clinical situations2-4. Success with 
the use of NIV is now well stabilised al-
though it can be limited by weaning failure 
requiring a more invasive approach or re-
institution of NIV. In fact, there is a paucity 
of information on weaning strategies from 
NIV. We aimed to evaluate the performance 
of a weaning strategies of NIV based on 
progressive periods of withdraw from NIV.
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Material and methods
During a one year period patients admit-
ted to a High Dependence Unit with acute 
exacerbations of Chronic Respiratory Fai-
lure (CRF) considered to non-invasive 
ventilation (NIV) were prospectively eval-
uated. We began NIV (in BiPAP mode) in 
patients with respiratory acidosis, defined 
by serum pH under 7.35, despite optimal 
medical therapy, not considered to imme-
diate invasive ventilation. Patients that did 
not adapt to a trial of NIV were not in-
cluded (4 patients).
Weaning was considered in patients pre-
senting simultaneously serum pH equal or 
superior to 7.35 and a respiratory rate (RR) 
inferior to 25 cpm for 24 hours. The wean-
ing protocol was based in increasing pe riods 
without NIV during a three days period. In 
day 1, during the day period in each 3 hours 
one hour was without NIV and two hours 
with NIV. During the night period, pa-
tients were under continuous NIV. In day 
2, during the day period during in each 3 
hours two hours were without NIV and 
one hour with NIV, keeping NIV continu-
ously during the night. In day 3, patients 
were without NIV during the day (only 
with supplementary oxygen delivered by 
mask) and with continuous NIV during 
the night.
Results
During the study period 78 patients with 
severe exarcebation of CRF were considered 
to NIV. Mean age 71.9 years (±10.1). Forty 
five patients were male.
CRF was due to Chronic obstructive pul-
monary disease in 80.8% of the patients 
(n=63), obesity in 23.1% of the patients 
(n=18), sequelae of pulmonary tuberculosis 
in 14.1% of patients (n=11), sleep apnoea 
in 5.1% (n=4) and thoracic deformity in 
2.6% (n=2) of patients. The causes of exac-
erbations of CRF were infection in 78.2% 
of the cases (n=61), non-therapeutic com-
pliance in 10.3% of the cases (n=8) and 
other causes in 11.6% (n=9). Twenty-nine 
patients (37.2%) had new infiltrate in the 
chest x-ray.
Thirty one patients were on long term oxy-
gen therapy and four on home NIV pre-
viously to hospitalization.
Of the 78 patients considered to NIV, four 
did not adapt to this ventilatory technique, 
two patients began invasive ventilation due 
to clinical deterioration and seven patients 
died during the NIV period. Sixty five pa-
tients achieved the stability previously re-
quired in order to begin weaning from 
NIV.
Serial arterial blood gases values and RR of 
patients connected and successful adapted 
Table – Serial blood gases and serial respiratory rate (RR) 
Admission First evaluation with NIV (within 3hours) Before discharge
Ph 7.24 (±0.79) 7.31 (±0.7) 7.44 (±0.4)
PaO2 (mmHg) 75 (±32) 73.6 (±26.9) 83.6  (±31.6)
PaCO2 (mmHg) 85.1 (±20.1) 76.8 (±18.9) 59.6 (±10.2)
HCO3 (mEq/L) 35.7 (±7) 33.8 (±3.5) 28.4 (±4.3)
RR (cpm) 28.3 (±8.1) 24.7 (±7.6) 17.3 (±3.3)
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to NIV are presented in the table. Once 
adapted to NIV, the pressure values that 
were used to stabilization were mean IPAP 
-20 mmHg (±3 mmHg) and mean EPAP – 
6.3 mmHg (±1.6). Oxygen was delivered in 
order to achieve peripheral saturation over 
90% (between 6 and 15 litres per minute). 
All patients were adapted to NIV with facial 
mask and all were on optimized medical 
therapy.
NIV was delivered between 17 and 192 
hours (mean 120.9 h ± 60.3 hours). No 
complications of NIV, namely nasal ulcers 
or red eye, were recorded. Time with acido-
sis ranged from 3 to 48 hours. All patients 
achieve successfully weaning from NIV. 
Twenty-four hours after the ending of our 
protocol the patients were discharged from 
our unit to the nursery. No patient had to 
be reconnected to NIV or used invasive 
ventilation during hospitalization
Discussion
Using NIV in patients with acute exacer-
bations of CRF is a therapeutic option that 
is becoming widely used in recent years. 
This clinical practice is based on several 
studies comparing NIV with invasive ven-
tilation5-7. Although, focusing specially in 
COPD patients7, multiple advantages have 
been associated with the use of NIV: re-
duction of the infectious complications re-
lated to the ventilator; reduction in airways 
lesion related to the oro-traqueal tube and 
reduction of the time of hospitalization as 
well of the costs6. This results and consen-
sus lead to the recommendation of this 
mode ventilatory model several forms of 
respiratory failure (chronic or acute)7,8. 
Our results on success of NIV (failure in 
16.3% of patients) is similar to other des-
cribed in the literature, and show that re-
sults from clinical trials can be translate to 
clinical practice9-14.
The use of NIV is well described in the 
weaning of invasive ventilation. Weaning 
from NIV is an issue with a paucity of in-
formation. In the weaning process of NIV, 
two fundamental approaches could be sug-
gested. One based on progressive periods 
of withdraw from NIV, other based in a 
progressive decrease in the inspiratory and 
expiratory pressures support. Despite these 
suggestions there is sparse information on 
weaning success rates provided by different 
approaches. We describe a weaning strate-
gy, based on increasing periods of NIV 
withdraw, with an excellent success rate 
but requiring a 72 hours period of wean-
ing. Our strategy lead to an overall total 
time of NIV superior to that reported in 
similar conditions15. This aspect is also re-
lated to the fact that in a small amount of 
patients we need to prolong some of the 
weaning phases (especially phase 2) for 
more than 24 hours. We did not consi-
dered this as a failure in weaning because 
after this modification in the timing pre-
dicted all patients were discharge of our 
unit with clinical and gasometric improve-
ment. Nevertheless, NIV was well support-
ed and we did not observe any complica-
tions or lateral effects associated.
Although interesting, our weaning approach 
is time consuming, patients had to stay at 
least three days to finish the weaning pro-
cess which is an important limitation to its 
feasibility in clinical practice. Less time con-
suming programs, based on progressive 
withdraw from NIV with similar success 
rate merits investigation.
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In summary, we report in a group of patients 
with exacerbation of respiratory failure requi-
ring NIV, a success of NIV of 83%. In the group 
of patients with clinical improvement due to 
NIV a total weaning success based on progres-
sive periods of NIV withdraw was reported.
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